KPV is a synthetic tripeptide consisting of lysine, proline, and valine(Lys-Pro-Val). Derived from the extensively studied hormone a-melanocyte-stimulating hormone (a-MSH), this fragment operatesindependently of the broader hormonal functions associated with itsparent molecule. In laboratory and controlled preclinical researchsettings, KPV has gained significant interest for its selective anti-inflammatory activity, structural simplicity, and stable biochemicalprofile. Despite its compact structure, the peptide demonstratesconsiderable relevance in research models focused on inflammatorypathways, epithelial barrier dynamics, and immune-signalingresponses.
Because KPV represents a specific portion of a-MSH, it maintainscertain mechanistic characteristics without exerting pigment-related orhormonal effects. These attributes make it a valuable tool forresearchers aiming to investigate inflammation-associated mechanismswhile avoiding activation of melanocortin-linked endocrine pathways.As ongoing studies continue to explore its potential, KPV remains anotable candidate for controlled laboratory experiments involvingcytokine behavior, mucosal environments, and dermal or epithelialresearch models.
Ongoing preclinical investigations continue to evaluate KPV in researchmodels involving cytokine regulation, mucosal environments, anddermal or epithelial systems. For laboratory consistency andreproducibility, KPv is commonly supplied as a high-purity, LPS-freepeptide, produced under controlled conditions. Each batch isformulated as an endotoxin-free peptide and undergoes verification asresearch peptides endotoxin tested, supporting its suitability forsensitive in-vitro and ex-vivo experimental applications.
For research use only. Not for human or animal use. This material isintended exclusively for laboratory and scientific research purposes.
